← Back to headlines
Corcept Therapeutics Stock Surges Following FDA Approval of Lifyorli
Corcept Therapeutics (CORT) shares climbed by 19.7% after its drug Lifyorli received approval from the FDA.
26 Mar, 01:01 — 26 Mar, 01:01
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Philippines receives diesel shipment from Malaysia
just now
Bulgaria Issues 12,000 Permits for Foreign Tourism Workers in Three Months
16m ago